首页> 外文期刊>Human Genetics >The natural history of OTOF-related auditory neuropathy spectrum disorders: a multicenter study
【24h】

The natural history of OTOF-related auditory neuropathy spectrum disorders: a multicenter study

机译:The natural history of OTOF-related auditory neuropathy spectrum disorders: a multicenter study

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Pathogenic variations in the OTOF gene are a common cause of hearing loss. To refine the natural history and genotype–phenotype correlations of OTOF-related auditory neuropathy spectrum disorders (ANSD), audiograms and distortion product otoacoustic emissions (DPOAEs) were collected from a diverse cohort of individuals diagnosed with OTOF-related ANSD by comprehensive genetic testing and also reported in the literature. Comparative analysis was undertaken to define genotype–phenotype relationships using a Monte Carlo algorithm. 67 audiograms and 25 DPOAEs from 49 unique individuals positive for OTOF-related ANSD were collected. 51 unique OTOF pathogenic variants were identified of which 21 were missense and 30 were loss of function (LoF; nonsense, splice-site, copy number variants, and indels). There was a statistically significant difference in low, middle, and high frequency hearing thresholds between missense/missense and LoF/missense genotypes as compared to LoF/LoF genotypes (average hearing threshold for low, middle and high frequencies 70.9, 76.0, and 73.4 dB vs 88.5, 95.6, and 94.7 dB) via Tukey’s test with age as a co-variate (P = 0.0180, 0.0327, and 0.0347, respectively). Hearing declined during adolescence with missense/missense and LoF/missense genotypes, with an annual mid-frequency threshold deterioration of 0.87 dB/year and 1.87 dB/year, respectively. 8.5% of frequencies measured via DPOAE were lost per year in individuals with serial tests. Audioprofiling of OTOF-related ANSD suggests significantly worse hearing with LoF/LoF genotypes. The unique pattern of variably progressive OTOF-related autosomal recessive ANSD may be amenable to gene therapy in selected clinical scenarios.

著录项

  • 来源
    《Human Genetics》 |2022年第4期|853-863|共11页
  • 作者单位

    Molecular Otolaryngology and Renal Research Laboratories, Department of Otolaryngology-Head and;

    Department of Otolaryngology,Guangdong Provincial People’s Hospital, Guangdong Academy of Medical;

    College of Otolaryngology Head and Neck Surgery,Chinese PLA Institute of Otolaryngology, ChineseShandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong UniversityCollege of Otolaryngology Head and Neck Surgery,Chinese PLA General Hospital, Chinese PLA MedicalNinth People’s Hospital, Shanghai Jiaotong University School of MedicineUniversity of Arkansas for Medical SciencesDallas Ear Institute,Dallas Hearing FoundationDepartment of Pediatric Otolaryngology,Children’s Hospital ColoradoMcKusick-Nathans Department of Genetic Medicine,Johns Hopkins Medical InstitutionsDepartment of Genetics,University of Alabama at BirminghamDor Yeshorim,The Committee of Preventing Jewish Genetic DiseasesMedical Genetics Department,King Faisal Specialist Hospital and Research CenterMedical Genetics Center,Southwest Hospital, Army Medical University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 医学遗传学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号